全文获取类型
收费全文 | 2712篇 |
免费 | 186篇 |
出版年
2022年 | 21篇 |
2021年 | 37篇 |
2020年 | 25篇 |
2019年 | 31篇 |
2018年 | 38篇 |
2017年 | 26篇 |
2016年 | 65篇 |
2015年 | 100篇 |
2014年 | 130篇 |
2013年 | 134篇 |
2012年 | 178篇 |
2011年 | 164篇 |
2010年 | 110篇 |
2009年 | 94篇 |
2008年 | 161篇 |
2007年 | 161篇 |
2006年 | 140篇 |
2005年 | 131篇 |
2004年 | 109篇 |
2003年 | 116篇 |
2002年 | 116篇 |
2001年 | 58篇 |
2000年 | 52篇 |
1999年 | 44篇 |
1998年 | 46篇 |
1997年 | 35篇 |
1996年 | 30篇 |
1995年 | 30篇 |
1994年 | 25篇 |
1993年 | 29篇 |
1992年 | 47篇 |
1991年 | 29篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 24篇 |
1987年 | 16篇 |
1986年 | 16篇 |
1985年 | 25篇 |
1984年 | 25篇 |
1983年 | 17篇 |
1982年 | 12篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 26篇 |
1978年 | 16篇 |
1977年 | 17篇 |
1976年 | 12篇 |
1975年 | 14篇 |
1973年 | 13篇 |
1972年 | 14篇 |
排序方式: 共有2898条查询结果,搜索用时 281 毫秒
81.
Brutpflegenden Nannacara anomala-♀♀ wurde die eigene Brut weggenommen und gegen jüngere oder ältere Nannacara-Brut bzw. entsprechende Ersatzobjekte ausgetauscht. Auch ohne vorangegangenes Ablaichen läßt sich Brutpflegeverhalten bei Nannacara-♀♀ durch Brutobjekte auslösen und aufrecht erhalten. Die auftretenden Verhaltensweisen passen zum jeweiligen Entwicklungsstadium der Brut. An der Synchronisation des Brutpflegeverhaltens sind sowohl endogene als auch exogene Faktoren beteiligt. Beim Fächeln zeigte sich eine stärkere Beteiligung endogener Faktoren als beim Kopfzucken. Das spricht dafür, daß zunächst die endogenen, später die exogenen Faktoren überwiegen. Auf das Fächeln wirken endogene Faktoren zunächst fördernd, später im Sinne einer Hemmung ein. 相似文献
82.
83.
84.
Federico Perozeni Stefano Cazzaniga Thomas Baier Francesca Zanoni Gianni Zoccatelli Kyle J. Lauersen Lutz Wobbe Matteo Ballottari 《Plant biotechnology journal》2020,18(10):2053-2067
The green alga Chlamydomonas reinhardtii does not synthesize high‐value ketocarotenoids like canthaxanthin and astaxanthin; however, a β‐carotene ketolase (CrBKT) can be found in its genome. CrBKT is poorly expressed, contains a long C‐terminal extension not found in homologues and likely represents a pseudogene in this alga. Here, we used synthetic redesign of this gene to enable its constitutive overexpression from the nuclear genome of C. reinhardtii. Overexpression of the optimized CrBKT extended native carotenoid biosynthesis to generate ketocarotenoids in the algal host causing noticeable changes the green algal colour to reddish‐brown. We found that up to 50% of native carotenoids could be converted into astaxanthin and more than 70% into other ketocarotenoids by robust CrBKT overexpression. Modification of the carotenoid metabolism did not impair growth or biomass productivity of C. reinhardtii, even at high light intensities. Under different growth conditions, the best performing CrBKT overexpression strain was found to reach ketocarotenoid productivities up to 4.3 mg/L/day. Astaxanthin productivity in engineered C. reinhardtii shown here might be competitive with that reported for Haematococcus lacustris (formerly pluvialis) which is currently the main organism cultivated for industrial astaxanthin production. In addition, the extractability and bio‐accessibility of these pigments were much higher in cell wall‐deficient C. reinhardtii than the resting cysts of H. lacustris. Engineered C. reinhardtii strains could thus be a promising alternative to natural astaxanthin producing algal strains and may open the possibility of other tailor‐made pigments from this host. 相似文献
85.
Leen Depauw Michael P. Perring Dries Landuyt Sybryn L. Maes Haben Blondeel Emiel De Lombaerde Guntis Brūmelis Jörg Brunet Déborah Closset-Kopp Guillaume Decocq Jan Den Ouden Werner Härdtle Radim Hédl Thilo Heinken Steffi Heinrichs Bogdan Jaroszewicz Martin Kopecký Ilze Liepiņa Martin Macek František Máliš Wolfgang Schmidt Simon M. Smart Karol Ujházy Monika Wulf Kris Verheyen 《应用植被学》2021,24(1):e12532
86.
87.
Olivia Weigert Caroline von Spee Reinmar Undeutsch Lutz Kloke Jens Y Humrich Gabriela Riemekasten 《Arthritis research & therapy》2013,15(1):R35
Introduction
The ability to ameliorate murine lupus renders regulatory T cells (Treg) a promising tool for the treatment of systemic lupus erythematosus (SLE). In consideration to the clinical translation of a Treg-based immunotherapy of SLE, we explored the potential of CD4+Foxp3+ Treg to maintain disease remission after induction of remission with an established cyclophosphamide (CTX) regimen in lupus-prone (NZBxNZW) F1 mice. As a prerequisite for this combined therapy, we also investigated the impact of CTX on the biology of endogenous Treg and conventional CD4+ T cells (Tcon).Methods
Remission of disease was induced in diseased (NZBxNZW) F1 mice with an established CTX regimen consisting of a single dose of glucocorticosteroids followed by five day course with daily injections of CTX. Five days after the last CTX injection, differing amounts of purified CD4+Foxp3+CD25+ Treg were adoptively transferred and clinical parameters, autoantibody titers, the survival and changes in peripheral blood lymphocyte subsets were determined at different time points during the study. The influence of CTX on the numbers, frequencies and proliferation of endogenous Treg and Tcon was analyzed in lymphoid organs by flow cytometry.Results
Apart from abrogating the proliferation of Tcon, we found that treatment with CTX induced also a significant inhibition of Treg proliferation and a decline in Treg numbers in lymphoid organs. Additional adoptive transfer of 1.5 × 106 purified Treg after the CTX regimen significantly increased the survival and prolonged the interval of remission by approximately five weeks compared to mice that received only the CTX regimen. The additional clinical amelioration was associated with an increase in the Treg frequency in the peripheral blood indicating a compensation of CTX-induced Treg deficiency by the Treg transfer.Conclusions
Treg were capable to prolong the interval of remission induced by conventional cytostatic drugs. This study provides valuable information and a first proof-of-concept for the feasibility of a Treg-based immunotherapy in the maintenance of disease remission in SLE. 相似文献88.
Dominik A. Megger Thilo Bracht Michael Kohl Maike Ahrens Wael Naboulsi Frank Weber Andreas-Claudius Hoffmann Christian Stephan Katja Kuhlmann Martin Eisenacher J?rg F. Schlaak Hideo A. Baba Helmut E. Meyer Barbara Sitek 《Molecular & cellular proteomics : MCP》2013,12(7):2006-2020
Proteomics-based clinical studies have been shown to be promising strategies for the discovery of novel biomarkers of a particular disease. Here, we present a study of hepatocellular carcinoma (HCC) that combines complementary two-dimensional difference in gel electrophoresis (2D-DIGE) and liquid chromatography (LC-MS)-based approaches of quantitative proteomics. In our proteomic experiments, we analyzed a set of 14 samples (7 × HCC versus 7 × nontumorous liver tissue) with both techniques. Thereby we identified 573 proteins that were differentially expressed between the experimental groups. Among these, only 51 differentially expressed proteins were identified irrespective of the applied approach. Using Western blotting and immunohistochemical analysis the regulation patterns of six selected proteins from the study overlap (inorganic pyrophosphatase 1 (PPA1), tumor necrosis factor type 1 receptor-associated protein 1 (TRAP1), betaine-homocysteine S-methyltransferase 1 (BHMT)) were successfully verified within the same sample set. In addition, the up-regulations of selected proteins from the complements of both approaches (major vault protein (MVP), gelsolin (GSN), chloride intracellular channel protein 1 (CLIC1)) were also reproducible. Within a second independent verification set (n = 33) the altered protein expression levels of major vault protein and betaine-homocysteine S-methyltransferase were further confirmed by Western blots quantitatively analyzed via densitometry. For the other candidates slight but nonsignificant trends were detectable in this independent cohort. Based on these results we assume that major vault protein and betaine-homocysteine S-methyltransferase have the potential to act as diagnostic HCC biomarker candidates that are worth to be followed in further validation studies.Hepatocellular carcinoma (HCC)1 currently is the fifth most common malignancy worldwide with an annual incidence up to 500 per 100,000 individuals depending on the geographic region investigated. Whereas 80% of new cases occur in developing countries, the incidence increases in industrialized nations including Western Europe, Japan, and the United States (1). To manage patients with HCC, tumor markers are very important tools for diagnosis, indicators of disease progression, outcome prediction, and evaluation of treatment efficacy. Several tumor markers have been reported for HCC, including α-fetoprotein (AFP) (2), Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) (3), and des-γ-carboxyl prothrombin (DCP) (4). However, none of these tumor markers show 100% sensitivity or specificity, which calls for new and better biomarkers.To identify novel biomarkers of HCC, many clinical studies using “omics”-based methods have been reported over the past decade (5–6). In particular, the proteomics-based approach has turned out to be a promising one, offering several quantification techniques to reveal differences in protein expression that are caused by a particular disease. In most studies, the well-established 2D-DIGE technique has been applied for protein quantification followed by identification via mass spectrometry (7–15). Even if the quantification is very accurate and sensitive in this gel-based approach, the relatively high amount of protein sample necessary for protein identification is the major disadvantage of this technique. Several mass-spectrometry-based quantitative studies using labeling-techniques like SILAC (stable isotope labeling by amino acids in cell culture) or iTRAQ (isobaric tags for relative and absolute quantification) have also been carried out for biomarker discovery of HCC (16–18). Here, the concomitant protein quantification and identification in a mass spectrometer allows high-throughput analyses. However, such experiments imply additional labeling reactions (in case of iTRAQ) or are limited to tissue culture systems (in case of SILAC). In the latter case, one can overcome the limitation by using the isotope-labeled proteins obtained from tissue culture as an internal standard added to a corresponding tissue sample. This approach is known as CDIT (culture-derived isotope tags) and was applied in a HCC study, very recently (19). Label-free proteomics approaches based on quantification by ion-intensities or spectral counting offer another possibility for biomarker discovery. These approaches are relatively cheap compared with the labeling approaches, because they do not require any labeling reagents and furthermore they allow for high-throughput and sensitive analyses in a mass spectrometer. A quantitative study of HCC using spectral counting has been reported (20), whereas to our knowledge an ion-intensity-based study has not been performed yet. Apart from these quantification strategies, protein alterations in HCC have been studied by MALDI imaging, as well. Here, the authors could show that based on its proteomic signature, hepatocellular carcinoma can be discriminated with high accuracy from liver metastasis samples or other cancer types (21) as well as liver cirrhosis (22). Based on these results, it could be assumed that MALDI imaging might be a promising alternative to standard histological methods in the future.Here, we report a quantitative proteomic study that combines two different techniques, namely the well-established 2D-DIGE approach and a label-free ion-intensity-based quantification via mass spectrometry and liquid chromatography. To our knowledge this is the first time such a combined study was performed with regard to hepatocellular carcinoma. By comparing the results of both studies, we aim to identify high-confident biomarker candidates of HCC, as gel- and LC-MS-based techniques are complementary. To verify the differential protein expressions detected in our proteomic studies we performed additional immunological verifications for selected proteins within two different sample sets (Fig. 1).Open in a separate windowFig. 1.Schematic representation of the applied workflow. 相似文献
89.
Jaciane Lutz Ienczak Willibaldo Schmidell Gláucia Maria Falcão de Aragão 《Journal of industrial microbiology & biotechnology》2013,40(3-4):275-286
This article gives an overview of high-cell-density cultures for polyhydroxyalkanoate (PHA) production and their modes of operation for increasing productivity. High cell densities are very important in PHA production mainly because this polymer is an intracellular product accumulated in various microorganisms, so a high cellular content is needed for the polymer production. This review describes relevant results from fed-batch, repeated batch, and continuous modes of operation without and with cell recycle for the production of these polymers by microorganisms. Finally, recombinant microorganisms for PHA production, as well future directions for PHA production, are discussed. 相似文献
90.
Craig P Hersh George R Washko Raúl San José Estépar Sharon Lutz Paul J Friedman MeiLan K Han John E Hokanson Philip F Judy David A Lynch Barry J Make Nathaniel Marchetti John D Newell Jr Frank C Sciurba James D Crapo Edwin K Silverman 《Respiratory research》2013,14(1):42